UPCOMING SESSIONS in ET
Thu, May 28, 2026
5:00 – 6:30 AM Bangkok
90-Minute Extended Session: TTR Inheritance, Genetic Testing & ACT-EARLY Trial Dr. Rachel Campagna Click To Register
UPCOMING SESSIONS in ET
Thu, May 28, 2026 · 5:00 – 6:30 AM Bangkok
90-Minute Extended Session: TTR Inheritance, Genetic Testing & ACT-EARLY Trial
Dr. Rachel Campagna
Click To Register
View all sessions

NICE (UK) positive for Beyonttra (acoramidis) for treating transthyretin amyloidosis with cardiomyopathy – Bayer

Published: Apr 02, 2026
Category
News
Source
Medical Update Online

NICE(UK): Acoramidis can be used, within its marketing authorisation, as an option to treat wild-type or hereditary transthyretin amyloidosis with cardiomyopathy in adults.

Acoramidis can only be used if the company provides it according to the commercial arrangement.

News Url
Read More